Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS One. 2012; 7(4): e34939.
Published online 2012 Apr 18. doi:  10.1371/journal.pone.0034939
PMCID: PMC3329531

Molecular-Phylogenetic Characterization of the Microbiota in Ulcerated and Non-Ulcerated Regions in the Patients with Crohn's Disease

Markus M. Heimesaat, Editor



The dysbiosis of intestinal microbiota has been established in Crohn's disease (CD), but the molecular characterization of this dysbiosis in Chinese subjects with CD remains unclear. This study aims to investigate the predominant bacterial composition of the faecal and mucosal-associated microbiota in Chinese CD patients using culture-independent techniques.

Methods/Principal Findings

Eighteen patients with CD and 9 healthy controls were included in this study. The faeces and the intestinal mucosal tissues from the ulcerated and nonulcerated sites were subjected to bacterial community fingerprinting using denaturing gradient gel electrophoresis (DGGE). The predominant bacterial composition in the faeces and mucosa was determined with DNA sequencing and BLAST. We showed that the bacterial diversity in the faeces of CD patients was reduced compared with that in healthy controls (p<0.01). The faecal bacterial dysbiosis of the patients was characterized by an elevated abundance of γ-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a reduced proportion of Bacteroidetes and Firmicutes. Five bacterial species defined the microbiota imbalance of the ulcerated mucosa in CD, including an increase in Escherichia coli, a decrease in Faecalibacterium prausnitzii, Lactobacillus coleohominis, Bacteroides sp and Streptococcus gallolyticus in the bacterial community as compared with the nonulcerated (p<0.01).


This is the first description of intestinal microbiota dysbiosis in Chinese CD patients. These results allow a better understanding of the faecal and mucosal microbiota in CD, showing a predominance of some opportunistic pathogenic bacteria and a decrease in beneficial bacterial species. The findings may provide novel insights into the pathogenesis of CD in Chinese population.


Crohn's disease (CD) is a chronic, recurrent inflammatory disorder of the gastrointestinal tract frequent in Western countries [1]. In recent years, CD incidence has been increasing in China [2], [3]. However, its aetiology is still unclear. CD is defined as a complex trait that results from the interaction between the host's genetic background and the resident commensal microbiota [4][7]. Recent studies suggest that changes in the gut microbiota play a part in the pathogenesis of CD [8][10]. The role of the commensal microbiota in the onset and perpetuation of the intestinal inflammation in CD is well established [11], [12]. A global decrease in the biodiversity and a markedly reduced diversity of Firmicutes, and in particular of the Clostridium leptum phylogenetic group are described as the specificities of the fecal microbiota in CD [13][15]. The composition of the mucosal and faecal microbiota has been demonstrated to be significantly different [16], [17]. The mucosal microbiota is of particular interest because the mucosal surface is the site of microbial recognition by the host [18]. CD is a disorder of mucosal inflammation and the mucosa-associated microbiota seems of peculiar relevance to the disease process [18], [19]. Abnormal composition of mucosa-associated microbiota in patients with CD has been found [18][20]. CD has increased amounts of bacteria attached to their gastrointestinal epithelial surfaces compared with healthy individuals and a proportional abundance of mucosa-associated Escherichia coli and Pseudomonas species [21][24]. Faecalibacterium prausnitzii was particularly depleted in ileocolonic mucosa-associated microbiota in CD [24], [25].

The human intestinal microbiota is a complex ecosystem containing hundreds of microbial species with a density exceeding 1012 bacteria per gram and it contributes to the host's nutrition, intestinal epithelial renewal and development of immune response [26], [27]. It is well established that the pathogenesis of CD is linked to microbial colonization, host genetics, environmental factors and immune dysfunction [4], [28][30]. Because the composition of the intestinal microbiota is likely to be influenced by genetic and environmental factors as well as dietary habits [16], [31], [32], the abnormal response of intestinal microbiota in CD might be driven by the genetic background and dietary custom in the host. Although supported by little evidence, the composition of intestinal microbiota in Chinese CD population may differ from that in Western countries. The changes of intestinal microbiota in Western population with CD have been broadly studied. However, the characterization of alterations in the composition and diversity of the intestinal microbiota in CD of Chinese population remains unknown.

The aim of the current study was to carry out a molecular analysis on the composition and diversity of the intestinal microbiota in Chinese patients with CD using denaturing gradient gel electrophoresis (DGGE) and DNA sequencing. This study was to compare the microbiological profiles of the faeces from CD patients and healthy controls and to identify the bacterial species characteristic of CD patients. We also determined the predominant bacterial composition of the mucosa-associated microbiota in the ulcerated ileum of CD patients. Our study was the first to define the changes of the intestinal microbiota in Chinese CD patients, which might provide novel knowledge on the role of intestinal bacterial dysbiosis in CD pathogenesis of Chinese population.



Eighteen patients (male/female: 10/8) with ileal CD and 9 healthy subjects (male/female: 5/4) were enrolled in this study. The median (range) ages were 35.2 (18–58) years for CD group and 33.7 (20–62) years for the controls. All participants were native residents in the mainland of China. The diagnosis of CD was made in accordance with established clinical, endoscopic, radiological, and histological criteria [33]. Disease activity was assessed by the Crohn's disease activity index (CDAI) [34] and all patients were in an active phase of disease (CDAI>150). Subjects taking antibiotics or probiotics within 4 weeks before sampling were excluded from the analyses.

The Ethics Committee for Human Medical Research of Jinling Hospital approved this study, and all participants gave written informed consent. Faeces were collected with sterile container from CD patients and healthy volunteers. The ileal mucosal specimens including the ulcerated and nonulcerated areas were surgically obtained from the patients. The tissue specimens were washed three times with normal saline and then stored at −80°C for DNA extraction.

DNA Extraction and Polymerase Chain Reaction (PCR)

DNA extraction of faecal samples was performed using a QIAamp DNA Stool Mini Kit (QIAGEN, Valencia, CA, USA) according to the manufacturer's instruction. Mucosa-associated bacterial DNA was extracted from ileal tissue sections by QIAamp DNA Mini Kit. The extracted DNA was checked by agarose gel electrophoresis (1% w/v) and were quantified spectrophotometrically. The hypervariable V3 region of 16S ribosomal RNA gene was amplified using PCR with universal bacterial primer sets (F357+GC clamp and R518) [35].


DGGE was performed using a DCode universal mutation system (Bio-Rad, Hercules, CA, USA). The sequence specific separation of PCR amplicons was conducted on 8% (w/v) polyacrylamide (acrylamide∶bisacrylamide, 37.5∶1) gels containing a urea-formamide gradient from 35 to 55% as previously described [36]. The electrophoresis was done at 120 V for 7.5 h at 60°C. The bands were stained with SYBR Green I (Invitrogen, Carlsbad, CA, USA) and imaged by UV transillumination with the ChemiDOC™ XRS instrument (Bio-Rad).

Comparative Analyses of DGGE Profiles

A scanned image of an electrophoretic gel was analyzed using QuantityOne software (Version 4.2, Bio-Rad). The similarities between DGGE profiles were assessed by the Dice coefficient and the unweighted pair group method with the arithmetic average (UPGMA) clustering algorithm, and the corresponding dendrograms were constructed. The relative abundance of each band was quantified by the staining intensity and was expressed as a proportion (%) of the sum of all fragments in the same lane of the gel [37]. The general diversity of bacterial communities was calculated according to Shannon and Wiener, as described previously [38], [39]. Principal component analysis (PCA) plots were generated based on the number of DGGE bands using the multivariate statistics software Canoco (version 4.5, Microcomputer Power, Ithaca, NY, USA).

Sequence Alignment and Phylogenetic Analysis

To identify the bacterial species correlated with the bands, selected products from the stained gels were excised with sterile scalpels. Gel slices were then incubated in 20 µl of elution buffer overnight at 4°C. Four µl of the resulting DNA solution was used as the template for re-amplification and PCR product was checked by DGGE as described previously [36]. The re-amplified fragments were purified and subjected to automated sequence analysis on an ABI PRISM 3730 sequencing system (Applied Biosystems, Foster City, CA, USA). The retrieved sequences were compared with the Genbank database using BLAST algorithm. Phylogenetic trees were generated via a neighbor-joining algorithm from evolutionary distances through the MEGA software (version 4.0).

Statistical Analysis

Data are presented as means ± standard deviation (SD). Statistical analysis was performed by Student's t test or one-way analysis of variance (ANOVA) followed by the Holme-Sidak test using the SPSS software (version 12.0). A p value of less than 0.05 was considered significant.


Shifts in Faecal Bacterial Microbiota

To assess the changes of the composition and diversity in gut microbiota, the faecal samples from CD patients and healthy controls were subjected to DGGE analysis. The representative DGGE profiles were presented in Figure 1A. The dendrogram based on DGGE banding patterns showed low similarities ranging from 27% to 42% in faecal bacterial communities between CD patients and healthy controls. And CD group and the controls were separated into two different clusters (Fig. 1B). Principal component analyses, based on the abundance of DGGE bands, also confirmed that the bacterial community profiles were distinctly different for the patients and healthy individuals (Fig. 2A). The data demonstrated large differences in faecal microbiota composition of CD patients from the healthy controls.

Figure 1
The dysbiosis of faecal microbiota in the patients with Crohn's disease (CD).
Figure 2
The plots of principal component analysis of microbiota composition and biodiversity from faecal samples.

The bacterial diversity, indicated as number of DGGE bands, was significantly reduced in CD patients compared with that in the controls (15.0±2.20 vs.19.9±2.58, p = 0.002) (Fig. 2B). The alternations of Shannon-Wiener diversity indices according to the number and intensity of bands were showed in Figure 2B. The mean diversity score was 2.19±0.13 for the patients and 2.58±0.21 for the healthy controls (p = 0.005), suggesting that the biodiversity of faecal microbiota in CD patients was decreased.

The Predominant Bacterial Composition of the Faecal Microbiota in CD Patients

It has been known that the changes of intestinal bacterial composition likely contributed to the pathogenesis of CD in Western population [8][10]. Therefore, we further identified the alternations of the dominant bacterial species in the faeces of Chinese CD patients in search of the potential bacteria associated with CD of Chinese population. Eighty-four sequences of 16S rRNA gene fragments were obtained from both CD and healthy faecal samples. These genes fell into 25 different phylotypes based on the highest sequence similarity (97–100%) matched to GenBank sequences (Fig. 1A, Tables 1 and and22).

Table 1
The sequence analysis of DGGE bands from the faeces of the patients.
Table 2
The sequence analysis of DGGE bands from the faeces of controls.

We quantified the relative abundance and frequency of fragments in DGGE profiles to identify which bacterial species might be involved in CD (Fig. 3). As shown in Fig. 3A and Table S1, the proportions of γ-Proteobacteria phylum, including Escherichia coli (F15), Shigella flexneri (F14), Enterobacteriaceae bacterium (F18) and Salmonella enterica (F9), were significantly increased in the patients as comparison with the control group (p<0.01). In contrast, most of Firmicutes bacteria detected in the faeces, such as Faecalibacterium prausnitzii (F7), Clostridium sp. (F6), Ruminococcus flavefaciens (F10), Enterococcus faecium (H2), Roseburia intestinalis (H5) and Bacillus coagulans (H8), showed a reduction in relative richness in the faecal microbiota of CD patients (p<0.01). However, Clostridium bolteae (F11) and Clostridium leptum (F13) were more abundant in CD patients than that in the controls (p<0.01). In addition, four bacteria of Bacteroidetes, Bacteroides sp. (H3), Bacteroides pectinophilus (H11), Bacteroides uniformis (H12) and Prevotella bryantii (H4) which dominated the faecal microbiota in the control group, were few present in CD patients (p<0.01). These results suggested that some opportunistic pathogenic γ-Proteobacteria greatly increased and became to be predominant in the faeces of CD patients instead of Bacteroides and Firmicutes. Analysis of sequence pools revealed significant differences in microbial community composition between CD patients and controls.

Figure 3
The relative abundance and frequency of predominant bacteria in faeces.

The Mucosa-associated Microbiota in Ulcerated and Nonulcerated Areas

It is important to note that the mucosal and faecal microbiota consist of distinct bacterial populations, and mucosa-associated microbes may be more important in CD pathogenesis [18], [19]. We profiled the bacterial composition and diversity in ileal mucosal specimens from the ulcerated and nonulcerated regions in CD patients (Fig. 4A). As shown in Figure 4B, the nonulcerated mucosal samples between different patients displayed higher similarities (>72%) and clustered together in the dendrogram. However, the banding patterns of the ulcerated mucosa were different from those in the nonulcerated tissues with lower similarities from 54% to 64%. The PCA plot clearly showed that the bacterial community composition was distinct between the ulcerated and nonulcerated specimens for both the first and the second principal component (Fig. 5A). Noticeably, the number of DGGE bands was fewer in the ulcerated mucosa (15.0±2.45) than that in the nonulcerated mucosa (18.3±1.21, p = 0.023) (Fig. 5B), suggesting a reduced diversity of bacterial community in the ulcerated areas in CD. Our results revealed that the mucosa-associated bacterial composition and diversity in the ulcerated regions was differentiated from the nonulcerated mucosa in CD.

Figure 4
Comparison of the mucosa-associated microbiota between the ulcerated and nonulcerated ileum.
Figure 5
The plots of principal component analysis of microbial composition and diversity in mucosa-associated microbiota.

The Bacterial Phylotypes Adhered in Ulcerated and Nonulcerated Mucosa

For a better understanding of the potential involvement between the mucosa-associated microbiota and CD, we next sought to determine the shifts of predominant bacterial composition in the intestinal mucosa of CD individuals (Fig. 6). Ten bacterial phylotypes were identified using DNA sequencing and BLAST analysis (Fig. 4A, Table 3) and the significant alternations in the richness were found between the ulcerated and nonulcerated specimens (Fig. 6A, Table S2). We observed that the relative abundance of Escherichia coli (M9), Clostridium difficile (M10), Clostridium sp. (M3) and Clostridium leptum (M7) were much higher in the ulcerated group than that in the nonulcerated (p<0.01) (Fig. 6A, Table S2). The intensity of four bands corresponding to Faecalibacterium prausnitzii (M5), Lactobacillus coleohominis (M6), Bacteroides sp. (M2) and Streptococcus gallolyticus (M1), was decreased significantly in the ulcerated mucosa compared with that in the control regions (p<0.01). It indicated that the elevated proportion of some opportunistic pathogenic bacteria might be associated with the inflammatory response and the formation of mucosal ulceration in CD (Fig. 7).

Figure 6
The relative richness and frequency of predominant microorganisms in mucosal specimens.
Table 3
The sequence analysis of DGGE bands from mucosal samples.
Figure 7
Histological characteristics of the ileal mucosa from CD patient.

Phylogenetic Analysis of the Predominant Bacteria

The sequences representing the respectively excised DGGE bands were phylogenetically analyzed by ClustalW and neighbor-joining alignment. The phylogenetic dendrogram showed that the dominant sequences from the faeces in CD patients were divided into 4 clusters (Fig. 8): Firmicutes (total 12 sequences: 7 of Clostridiales; 1 of Lactobacillales, 4 of others), Bacteroidetes (total 4 sequences, 4 of Bacteroidales), γ-Proteobacteria (total 5 sequences: 4 of Enterobacteriales, 1 of others) and ε-Proteobacteria (1 sequence). In the healthy controls, the sequences were belonged to 3 clusters: Firmicutes (total 10 sequences: 6 of Clostridiales; 1 of Lactobacillales, 1 of Bacillales, 1 of others), Bacteroidetes (total 5 sequences: 5 of Bacteroidales), γ-Proteobacteria (1 sequence, 1 of Enterobacteriales). It revealed that the predominant bacterial composition in the faeces was altered and the Proteobacteria phylum was overrepresented in patients with CD.

Figure 8
Phylogenetic tree generated from the 16S rDNA sequences of predominant bacterial species in the faeces.

Ten dominant sequences obtained from the mucosal specimens were phylogenetically clustered into 3 phylum (Fig. 9): Firmicutes (total 7 sequences: 4 of Clostridiales; 2 of Lactobacillales, 1 of Bacillales), Bacteroidetes (Bacteroidales: 1 sequence) and γ-Proteobacteria (2 sequences, 2 of Enterobacteriales:). The dominant mucosa-associated microbiota showed greater differences from the dominant fecal microbiota in CD patients.

Figure 9
Phylogenetic relationship of 16S rDNA sequences obtained from the mucosal specimens of CD patients.


In this study, we used culture-independent techniques to characterize the intestinal microbiota dysbiosis in the faeces and ileal mucosa of Chinese patients with CD. Cluster analysis of the bacterial profiles in faecal samples showed distinct clustering of CD patients and controls. The biodiversity of faecal microbiota was reduced in CD patients. The dysbiosis signature we found in Chinese patients with CD was markedly characteristic by an increase of the richness of some opportunistic pathogenic γ-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a decrease of the proportion of Firmicutes and Bacteroides. The profiles of the mucosa-associated microbiota in CD patients demonstrated that the predominant composition of bacteria attached to the ulcerated mucosa was distinguishable from that in the nonulcerated area. The diversity of the microbiota in the ulcerated sites was decreased in comparison to that in the nonulcerated mucosa. The relative abundance of Escherichia coli and Clostridium spp. were found to be much higher in the ulcerated mucosa than that in the nonulcerated. Faecalibacterium prausnitzii, Lactobacillus coleohominis, Bacteroides sp. and Streptococcus gallolyticus were decreased significantly in the richness in the ulcerated mucosa. Our study demonstrated the molecular characteristic of the intestinal microbiota dysbiosis in the faeces and the mucosal tissues in Chinese population with CD.

Previous studies have provided evidence of the roles of the intestinal microbiota in the development and/or progression of CD [8][10]. The intestinal microbiota of patients with both active and inactive CD differs from that of healthy subjects [20]. However, the dysbiosis of intestinal bacterial community in Chinese CD patients is still unknown. In the present study, we profiled the bacterial composition and diversity of the fecal samples obtained from Chinese patients with CD. Large differences in the fecal microbiota were presented between the individuals with CD and healthy controls. We showed a reduced bacterial diversity in CD individuals compared to healthy controls, which was consistent with numerous other reports in Western populations with CD [14], [15]. This is the first finding that specifically pointed to a lower diversity for Chinese population subjects with CD.

Sequence analysis of 16S rRNA gene fragments provided the detailed description of the bacterial composition in the faeces of CD patients. Our results showed that the dominant bacterial species were altered in the faeces of CD patients, which was characterized by an overrepresentation of γ-Proteobacteria and a relative lack of Firmicutes and Bacteroidetes phylum. We observed that Escherichia coli, a major member of γ-Proteobacteria, had a significantly elevated abundance and became to be dominant in the faeces from CD patients. This finding corroborated recent researches suggesting a possible link between Escherichia coli and the pathogenesis of CD [21][23], [40], [41]. Our another important finding was a decreased proportion of Firmicutes phylum, in particular of Faecalibacterium prausnitzii in the faecal microbiota of CD patients. Faecalibacterium prausnitzii has been known as a potent anti-inflammatory commensal organism [42]. Our data suggested that Faecalibacterium prausnitzii might be negatively associated with CD, which was consistent with the results of previous studies [24], [25], [42]. The other members of Firmicutes, including Clostridium sp. Ruminococcus flavefaciens, Enterococcus faecium, Roseburia intestinalis and Bacillus coagulans were also observed markedly decreased in the faeces in CD patients. These Gram positive anaerobic bacteria usually account for a major fraction of the faecal microbiota in healthy subjects [31]. The data indicated that a reduced richness of Firmicutes might be implicated in the pathogenesis of CD. In addition, the quantitative composition of Bacteroides spp. population was significantly decreased in CD patients compared with the normal controls. Seksik et al. also found a decreased population level of Bacteroidetes in the faeces from CD patients [17]. A group-specific molecular analysis showed a significant low diversity of Bacteroides in the faecal microbiota of CD patients [18], [19]. However, the studies of Bacteroidets in CD are still controversial. Several culture studies have shown a possible increase of Bacteroides spp. population level in CD [43], [44].

Apart from that, we demonstrated some unique characteristics of faecal bacterial imbalance in Chinese CD patients. We found that Shigella flexneri was more prevalent and abundant in CD patients but not present in healthy individuals. Some opportunistic pathogenic Proteobacteria such as Enterobacteriaceae bacterium, Salmonella enterica and Helicobacter Canadensis were also found occasionally in CD patients. These bacterial species were all absent from the previous investigation of CD. In addition, an elevated richness of Clostridium bolteae and Clostridium leptum was detected in CD patients and it was not consistent with the previous results. It was usually thought that the Clostridium phylogenetic group, especially Clostridium leptum subgroup, was low abundant in CD patients compared with the healthy subjects [13], [17]. Veillonella dispar and Veillonella sp. that was abundant in healthy controls were absent from the dominant biota of CD patients (p<0.01; Fig. 1A, Table S1), which was few involved in CD in previous studies. These findings appeared different from the results obtained from Western subjects with CD. It has been known that the composition of intestinal microbiota is influenced by genetic background and food custom [31], [32], [45], [46]. Previous study has reported that the variants of NOD2 and other IBD genes in Chinese CD patients were distinct from Western CD patients [47]. So it was probable that human genetic background might be responsible for the differences of intestinal microbiota in Chinese patients. Furthermore, different dietary habits might be another important reason for the variations of intestinal microbiota between Chinese and Western subjects [48], [49]. Our current data might provide new bacterial species linked to active CD in China.

A relationship between disturbed microbiota and mucosal inflammation has not been established. Because mucosa-associated microbial species is close proximity to the host epithelium, the bacteria attached in intestinal mucosa are more likely to be involved in the inflammatory response of the gut than the luminal counterparts [18], [19]. It has been recognized that the intestinal mucosa-associated microbiota differs substantially from the fecal microbiota [16], [18]. However, the mucosa-associated microbiota in CD is poorly known, especially for inflammatory settings in CD patients. In this study, we used molecular phylogenetic analysis to characterize the mucosal microbiota and compared the differences of predominant bacterial composition between the ulcerated and nonulcerated tissues in the patients with ileal CD. As expected from previous studies of the mucosa-associated microbiota in Western CD subjects [18][20], we observed a decreased biodiversity of bacteria biota in the ulcerated mucosa in Chinese patients. The dominant bacterial structures in the ulcerated and the nonulcerated tissues showed low similarity, which were not in agreement with previous work [50]. Although the prevalence of the predominant microbial species were similar (Fig. 6B), their relative abundance was shifted in the ulcerated mucosa as compared with the nonulcerated areas (Fig. 6A), which was a major contributor for the lower similarity between the two different sites. The quantitative analysis of 16S rDNA fragments showed that Escherichia coli was more abundant in the ulcerated sites of intestinal mucosa than that in the nonulcerated mucosa. Increased abundance of Escherichia coli in biopsies from CD patients has previously been reported [13], [16], [19], [21][24]. These findings indicated that Escherichia coli was specifically associated with ulceration in CD patients [21][23]. Similar to previous results obtained from Western CD patients [24], [25], Faecalibacterium prausnitzii were less dominant in ulcerated mucosa in CD patients. In addition, the relative richness of Bacteroides sp., Lactobacillus coleohominis and Streptococcus gallolyticus were decreased significantly in the ulcerated mucosa, which was few detected in mucosa-associated microbiota in the previous study. The decreased richness of these bacterial species may be resulted from the overgrowth of the pathogens attached in the ulcerated sites. These differences between the ulcerated and the nonulcerated mucosa may reflect the altered nature of the mucus present on the mucosal surface of CD patients. The bacterial dysbiosis in the ulcerated mucosa of CD patients may be closely associated to the inflammatory response and disrupted mucosal structure seen in CD patients (Fig. 7).

In summary, we reported the results of a prospective study on intestinal microbiota in Chinese patients with CD. The present study defined for the first time the molecular characteristics of intestinal microbiota dysbiosis in Chinese CD subjects. We identified a reduced biodiversity of faecal bacterial community in CD. The faecal bacterial dysbiosis in CD patients was characterized by an increase of the richness γ-Proteobacteria (especially Escherichia coli and Shigella flexneri) and a reduced proportion of Bacteroides and Firmicutes. For mucosa-associated microbiota, we demonstrated a decrease of bacterial diversity in the ulcerated mucosa compared with that in the nonulcerated sites. In addition, the quantitative composition of the bacteria adhered to the ulcerated areas was different from that in the nonulcerated mucosa, which was mainly characteristic by an elevated Escherichia coli level and a reduction of Faecalibacterium prausnitzii, Lactobacillus coleohominis, Bacteroides sp and Streptococcus gallolyticus in the ulcerated sites. Taken together, we demonstrated an overrepresentation of some opportunistic pathogenic bacteria and a decrease in beneficial bacterial species in intestinal microbiota of Chinese CD patients, which indicated a possible relationship between some bacteria and the origin of CD. These findings may provide new clues into determining the aetiological mechanisms of CD in China.

Supporting Information

Table S1

Differences of the predominant bacterial species in the faeces from CD patients and healthy controls.


Table S2

Differences of the predominant bacterial species adhered in the ulcerated and nonuclerated mucosa.



We thank the Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany) for Dr. Qiurong Li.


Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by the National Natural Science Foundation in China (81070375), Key Project of National Natural Science Foundation in China (30830098), National High-tech R&D Program (863 Program) of China (2012AA021007), National Basic Research Program (973 Program) in China (No. 2009CB522405) and Scientific Research Fund in Jiangsu Province (BK2009317). The funders of the study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Loftus EJ. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–1517. [PubMed]
2. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn's disease in the Chinese population. Inflamm Bowel Dis. 2004;10:646–651. [PubMed]
3. Zheng JJ, Zhu XS, Huangfu Z, Shi XH, Guo ZR. Prevalence and incidence rates of Crohn's disease in mainland China: A meta-analysis of 55 years of research. J Digest Dis. 2010;11:161–166. [PubMed]
4. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599–603. [PubMed]
5. Cho JH, Nicolae DL, Gold LH, Fields CT, LaBuda MC, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p,3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA. 1998;95:7502–7507. [PMC free article] [PubMed]
6. Hugot JP, Alberti C, Berrebi D, Bingen E, Cézard JP. Crohns disease: the cold chain hypothesis. Lancet. 2003;362:2012–2025. [PubMed]
7. Elson CO. Genes, microbes, and T cells: new therapeutic targets in Crohn's disease. N Engl J Med. 2002;346:614–616. [PubMed]
8. Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991;338:771–774. [PubMed]
9. D'Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262–267. [PubMed]
10. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134:577–594. [PubMed]
11. Marteau P, Lepage P, Mangin I, Suau A, Doré J, et al. Gut flora and inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20:18–23. [PubMed]
12. Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, et al. The role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24:11–18. [PubMed]
13. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:106–111. [PubMed]
14. Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006;55:205–211. [PMC free article] [PubMed]
15. Andoh A, Tsujikawa T, Sasaki M, Mitsuyama K, Suzuki Y, et al. Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis. Aliment Pharmacol Ther. 2009;29:75–82. [PubMed]
16. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, et al. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol. 2002;68:3401–3407. [PMC free article] [PubMed]
17. Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, et al. Alterations of dominant fecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52:237–242. [PMC free article] [PubMed]
18. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44–54. [PubMed]
19. Kleessen B, Kroesen AJ, Buhr HJ, Blaut M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol. 2002;37:1034–1041. [PubMed]
20. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut. 2004;53:685–693. [PMC free article] [PubMed]
21. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004;127:80–93. [PubMed]
22. Sasaki M, Sitaraman SV, Babbin BA, Gerner-Smidt P, Ribot EM, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007;87:1042–1054. [PubMed]
23. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998;115:1405–1413. [PubMed]
24. Martinez-Medina M, Aldeguer X, Gonzalez-Huix F, Acero D, Garcia-Gil LJ. Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis. Inflamm Bowel Dis. 2006;12:1136–1145. [PubMed]
25. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. 2007;104:13780–137805. [PMC free article] [PubMed]
26. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, et al. Molecular analysis of commensal host microbial relationships in the intestine. Science. 2001;291:881–884. [PubMed]
27. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science. 2001;292:1115–1118. [PubMed]
28. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603–606. [PubMed]
29. Sartor RB. Enteric microflora in IBD: pathogens or commensals? Inflamm Bowel Dis. 1997;3:230–235. [PubMed]
30. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512–519. [PubMed]
31. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. Diversity of the human intestinal microbial flora. Science. 2005;30:1635–1638. [PMC free article] [PubMed]
32. Dicksved J, Flöistrup H, Bergström A, Rosenquist M, Pershagen G, et al. Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl Environ Microbiol. 2007;73:2284–2289. [PMC free article] [PubMed]
33. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24:2–6 (Suppl). [PubMed]
34. Best WR, Becktel JM, Singleton JW, Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439–444. [PubMed]
35. Vanhoutte T, De Preter V, De Brandt E, Verbeke K, Swings J, et al. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of Lactulose and Saccharomyces boulardii. Appl Environ Microbiol. 2006;72:5990–5997. [PMC free article] [PubMed]
36. Li Q, Zhang Q, Wang C, Tang C, Zhang Y, et al. Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoSONE. 2011;6:e20460. [PMC free article] [PubMed]
37. Bercik P, Denou E, Collins J, Jackson W, Lu J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141:599–609. [PubMed]
38. Shanon CW, Weaver W. Mathematical theory of communication. University of Illinois Press, Urbana; 1963.
39. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004;127:412–421. [PubMed]
40. El-Tawil AM. High incidence of Crohn's disease in pre-menopausal women: Escherichia coli may be contributing. Int J Colorectal Dis. 2004;19:498. [PubMed]
41. Darfeuille-Michaud A. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohns disease. Int J Med Microbiol. 2002;292:185–193. [PubMed]
42. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA. 2008;105:16731–16736. [PMC free article] [PubMed]
43. Ruseler-van Embden JG, Both-Patoir HC. Anaerobic gram-negative faecal flora in patients with Crohn's disease and healthy subjects. Antonie Van Leeuwenhoek. 1983;49:125–132. [PubMed]
44. Giaffer MH, Holdsworth CD, Duerden BI. The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique. J Med Microbiol. 1991;35:238–243. [PubMed]
45. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, et al. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol. 1989;55:1100–1105. [PMC free article] [PubMed]
46. Lay C, Rigottier-Gois L, Holmstrøm K, Rajilic M, Vaughan EE, et al. Colonic microbiota signatures across five northern European countries. Appl Environ Microbiol. 2005;71:4153–4155. [PMC free article] [PubMed]
47. Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, et al. Genetics of inflammatory bowel disease in Asia: Systematic review and meta-analysis. Inflamm Bowel Dis 2011 . doi: 10.1002/ibd.21845. [PubMed]
48. Mai V, McCrary QM, Sinha R, Glei M. Associations between dietary habits and body mass index with gut microbiota composition and fecal water genotoxicity: an observational study in African American and Caucasian American volunteers. Nutrition J. 2009;8:49. [PMC free article] [PubMed]
49. Mai V, Katki HA, Harmsen H, Gallaher D, Schatzkin A, et al. Effects of a controlled diet and black tea drinking on the fecal microflora composition and the fecal bile acid profile of human volunteers in a double-blinded randomized feeding study. J Nutr. 2004;134:473–478. [PubMed]
50. Bibiloni R, Mangold M, Madsen KL, Fedorak RN, Tannock GW. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol. 2006;55:1141–1149. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Gene (nucleotide)
    Gene (nucleotide)
    Records in Gene identified from shared sequence and PMC links.
  • MedGen
    Related information in MedGen
  • Nucleotide
    Primary database (GenBank) nucleotide records reported in the current articles as well as Reference Sequences (RefSeqs) that include the articles as references.
  • PubMed
    PubMed citations for these articles
  • Taxonomy
    Taxonomy records associated with the current articles through taxonomic information on related molecular database records (Nucleotide, Protein, Gene, SNP, Structure).
  • Taxonomy Tree
    Taxonomy Tree

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...